Approach; measures of infection prevalence included; model form | Validation period | Predictor set | C-statistic | |||||
---|---|---|---|---|---|---|---|---|
Age 18–<70 | Age 70–<80 | Age 80+ | ||||||
Female | Male | Female | Male | Female | Male | |||
(A), none, Cox | 1 | Age-sex | 0.809 | 0.834 | 0.580 | 0.575 | 0.641 | 0.533 |
Comorbidities | 0.887 | 0.917 | 0.842 | 0.772 | 0.772 | 0.641 | ||
COVID-AGE | 0.908 | 0.915 | 0.833 | 0.762 | 0.720 | 0.631 | ||
Selected | 0.876 | 0.910 | 0.838 | 0.785 | 0.765 | 0.651 | ||
Full | 0.892 | 0.929 | 0.846 | 0.789 | 0.762 | 0.662 | ||
2 | Age-sex | 0.794 | 0.815 | 0.593 | 0.560 | 0.631 | 0.633 | |
Comorbidities | 0.895 | 0.888 | 0.775 | 0.730 | 0.705 | 0.688 | ||
COVID-AGE | 0.906 | 0.888 | 0.765 | 0.733 | 0.698 | 0.679 | ||
Selected | 0.888 | 0.892 | 0.813 | 0.776 | 0.746 | 0.731 | ||
Full | 0.921 | 0.915 | 0.835 | 0.796 | 0.776 | 0.763 | ||
3 | Age-sex | 0.832 | 0.819 | 0.570 | 0.600 | 0.655 | 0.650 | |
Comorbidities | 0.905 | 0.890 | 0.784 | 0.735 | 0.706 | 0.708 | ||
COVID-AGE | 0.907 | 0.897 | 0.808 | 0.721 | 0.711 | 0.701 | ||
Selected | 0.910 | 0.890 | 0.837 | 0.792 | 0.747 | 0.750 | ||
Full | 0.918 | 0.908 | 0.856 | 0.830 | 0.780 | 0.783 | ||
(B), modelled estimates, Poisson | 1 | Age-sex | 0.814 | 0.851 | 0.709 | 0.634 | 0.723 | 0.607 |
Comorbidities | 0.884 | 0.918 | 0.856 | 0.773 | 0.790 | 0.668 | ||
Selected | 0.862 | 0.906 | 0.861 | 0.765 | 0.789 | 0.679 | ||
Full | 0.890 | 0.928 | 0.863 | 0.786 | 0.786 | 0.688 | ||
2 | Age-sex | 0.808 | 0.828 | 0.625 | 0.583 | 0.634 | 0.648 | |
Comorbidities | 0.897 | 0.889 | 0.778 | 0.733 | 0.706 | 0.697 | ||
Selected | 0.894 | 0.895 | 0.825 | 0.786 | 0.767 | 0.751 | ||
Full | 0.923 | 0.915 | 0.836 | 0.799 | 0.777 | 0.765 | ||
3 | Age-sex | 0.835 | 0.836 | 0.638 | 0.611 | 0.692 | 0.684 | |
Comorbidities | 0.900 | 0.897 | 0.797 | 0.740 | 0.724 | 0.727 | ||
Selected | 0.900 | 0.889 | 0.852 | 0.794 | 0.781 | 0.772 | ||
Full | 0.919 | 0.908 | 0.863 | 0.824 | 0.793 | 0.792 |